Drugmaker Affymax Inc (AFFY.O) said it was considering selling itself or filing for bankruptcy as it struggles to stay afloat following the recent recall of its sole commercial product, the anemia drug, Omontys. The stock plunged 63.7 percent to $1.07.
Firstpost · 3/19/2013
Drugmaker Vivus Inc. (NASDAQ: VVUS) said regulators will take a three ... has been appointed to the company’s board of directors, effective today. Affymax, Inc. (Nasdaq: AFFY) today announced that it has received a $50 million development milestone ...
Proactive Investors UK · 4/10/2012
“We thought about competing with Affy [initially], but given that they have ten times ... And once the chip has been designed, febit will keep it in stock if requested. “We’re encouraging people to run a trial first, including the design of a chip.
Bio IT World · 6/26/2015
What a difference a day makes. Investors bid up the shares of Affymax (NASDAQ:AFFY) 19% Monday after an Food & Drug Administration report said the company’s anemia drug is comparable in effectiveness to medications for patients with chronic …
Investor Place · 12/7/2011
This free program will calculate the probabilities of AMERICAN GRAPHITE TECHNOLOGIES INC. (AGIN) stock chart Watch the video to learn about the probability of AMERICAN GRAPHITE TECHNOLOGIES INC. (AGIN) Chart Signal as of Aug 10, 2015
Hot Stocked · 7/3/2013
The indices look strong this morning and breadth is nearly 4-to-1 positive, but under the surface I'm not seeing the sort of frenzied buying those facts might suggest. In fact, I'm seeing quite a few fades, and key names like Apple (AAPL) don't seem to be ... · 7/13/2012
Severe hypersensitivity reactions in Omontys patients prompted Affymax ($AFFY) and Takeda Pharmaceutical to recall all lots of the anemia drug, designed for use in dialysis patients. The FDA says it received reports of 19 serious reactions; three of those ...
FiercePharma · ByTracy Staton · 2/24/2013
And now Alfonso is set to trade in his dancing shoes and reinvent himself one more time as he becomes the host of “Unwrapped 2.0” on the Cooking ... Favorites such as Lemonheads and Affy Tapple caramel apples will be on-hand, too, along with …
Examiner · 1/27/2015
"In our international tables, Affymax, Inc. (AFFY) experienced steady trading by TD clients, appearing as an equal third most popular buy and sell, with a buy:sell ratio of approximately 1:1. The biopharmaceutical company recently announced significant ...
Easier · 5/16/2013
bluebird bio Inc. (BLUE) experienced unusually high volume on May. 21, as the stock gained 4.36% to a closing price of $172.94. The stock saw 1.9 million shares trade hands over the course of the day on 16,646 trades. Given that the stock’s average …
Equities · 5/21/2015